Erythromycin

红霉素

Report date: 2026/03/04 20:01:44
NME

Base Information

Drug NameErythromycin
Drug Alias NameErythromycinum红霉索EritromicinaE-MycinEryacne +[9] 
ClassificationSmall molecules > Heterocyclic drugs > Antibiotics > Macrolides antibiotics
Mechanisms of Action50S ribosomal subunit inhibitors
Targets50S ribosomal subunit
Therapy Area/IndicationsBulimia NervosaFeeding and Eating DisordersAcne Vulgaris +[5] 
Global Approved IndicationsBacterial Infections
Approved Indications in ChinaBacterial Infections
Original Approved Country/TerritoryUnited States
Original Approved Date1952/01/01
Country/TerritoryUnited StatesPakistanMainland China +[4] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesN/A
China Registration ClassN/A

Develop Information

Active CompaniesDistrict Headquarters Teaching Hospital SahiwalHikma PharmaceuticalsDalian Tianyu Pharmaceutical Co Ltd
Inactive CompaniesDista SaNew York State Psychiatric InstituteWestwood - Squibb Pharmaceuticals Inc
Active IndicationsFetal Membranes, Premature RuptureBacterial Infections
Inactive IndicationsBulimia NervosaFeeding and Eating DisordersAcne Vulgaris

Other Information

ATC CodeD10AF02J01FA01S01AA17
Related LinksDrugBankKEGG